Tag: Mylan

EpiPen Pricing Controversy Reveals Ignorance about Market Competition »

Increased competition is the remedy to skyrocketing drug prices.

One Solution to the EpiPen Crisis: Repeal Durham-Humphrey! »

Posturing politicians on Capitol Hill conducted a hearing a few days ago during which they grilled Heather Bresch, CEO of Mylan N.V., maker of EpiPens. Prices of EpiPens have skyrocketed in the past few years (which I have discussed here and here). The politicians were more interested in wagging their fingers and tut-tutting at...
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org